HC Wainwright & Co.下调评级HOOKIPA Pharma评级为中性

同花顺iNews
10 Jan

同花顺美股讯 1月10日HC Wainwright & Co.将hookipa pharma评级从买入下调评级为中性。HOOKIPA Pharma于11月14日发布2024年三季报,公司截至2024年9月30日,营业收入4259.20万美元,同比234.79%,净利润-1855.30万美元,基本每股收益-1.48美元。HOOKIPA Pharma Inc.于2017年2月根据特拉华州法律以...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10